Filters : "Hohman, T." Limpar


  • Source: Mediators of Inflammation. Conference title: World Congress on Inflamation. Unidade: ICB

    Subject: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CRUZ, J. W. M. C. e HOHMAN, T. e FORTES, Zuleica Bruno. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 30 jun. 2022. , 1999
    • APA

      Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
    • NLM

      Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]
    • Vancouver

      Cruz JWMC, Hohman T, Fortes ZB. Polyol Pathway products are involved in the defective endothelial-leucocyte interaction in diabetes mellitus (DM). Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]
  • Source: Mediators of Inflammation. Conference title: World Congress on Inflamation. Unidade: ICB

    Subject: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CRUZ, J. W. M. C. e HOHMAN, T. e FORTES, Zuleica Bruno. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 30 jun. 2022. , 1999
    • APA

      Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
    • NLM

      Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]
    • Vancouver

      Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leucocyte interaction is observed in galactosemia, a model of diabetic complications. Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]
  • Source: Mediators of Inflammation. Conference title: World Congress on Inflamation. Unidade: ICB

    Subject: FARMACOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      AKAMINE, E. H. et al. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo. . Acesso em: 30 jun. 2022. , 1999
    • APA

      Akamine, E. H., Cruz, J. W. M. C., Hohman, T., & Fortes, Z. B. (1999). Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. Paris: Instituto de Ciências Biomédicas, Universidade de São Paulo.
    • NLM

      Akamine EH, Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]
    • Vancouver

      Akamine EH, Cruz JWMC, Hohman T, Fortes ZB. Defective endothelial-leukocyte interaction in galactosemia: polyol pathway activation. Mediators of Inflammation. 1999 ; 8( 1):[citado 2022 jun. 30 ]

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2022